Related Experiment Video
Updated: Jan 10, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention: A Comprehensive Review
Mohammed Ferras Dabbagh1, Zachary Morrow2, Rajiv Tayal3
1Division of Cardiology, Department of Medicine, Emory University School of Medicine, Emory University, Atlanta, GA, USA.
Insights
Chronic Total Occlusions (CTOs) are complex blockages treated with percutaneous coronary intervention (PCI). Prophylactic use of Mechanical Circulatory Support (MCS) devices can improve procedural success in high-risk CTO PCI patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Chronic Total Occlusions (CTOs) represent complete coronary artery blockages exceeding three months.
- CTO percutaneous coronary intervention (PCI) offers symptom relief and improved cardiac function but carries higher complication risks.
- Mechanical Circulatory Support (MCS) devices are increasingly utilized for high-risk PCI procedures.
Purpose of the Study:
- To evaluate the role and impact of Mechanical Circulatory Support (MCS) devices in high-risk patients undergoing Chronic Total Occlusion (CTO) percutaneous coronary intervention (PCI).
- To assess how prophylactic MCS use influences procedural success and outcomes in CTO PCI.
Main Methods:
- Review of clinical trials, meta-analyses, and registries evaluating MCS use in CTO PCI.
- Analysis of patient selection criteria and risk stratification for MCS implementation.
- Assessment of procedural success rates and complication profiles with and without prophylactic MCS.
Main Results:
- Prophylactic use of MCS devices (e.g., Impella, TandemHeart, VA-ECMO) is associated with improved procedural success in CTO PCI.
- Indications for MCS include severe left ventricular dysfunction, complex coronary anatomy, and comorbidities.
- Careful patient selection and risk stratification are crucial for optimizing MCS benefits.
Conclusions:
- Mechanical Circulatory Support (MCS) is a valuable tool for managing high-risk patients undergoing complex Chronic Total Occlusion (CTO) percutaneous coronary intervention (PCI).
- Prophylactic MCS can enhance procedural success rates, but judicious patient selection is paramount.
- Further research and risk stratification strategies are essential to maximize the benefits of MCS in CTO PCI.
Abstract:
Chronic Total Occlusions (CTOs) are complete coronary artery blockages persisting for more than three months. CTOs present significant technical and hemodynamic challenges during prercutaneous coronary intervention (PCI). CTO PCI can substantially improve symptoms, quality of life, and left ventricular function. However, CTO PCI is associated with higher procedure complications rates. Mechanical Circulatory Support (MCS) devices, such as Impella, TandemHeart, and VA-ECMO, have emerged as critical tools for high-risk patients. Indications for MCS include severe left ventricular dysfunction, complex coronary anatomy, and multiple comorbidities. Evidence from clinical trials, meta-analyses, and regiestries demonstrate that prophylactic MCS use can improve procedural success. Careful patient selection and risk stratification are essential to maximize the benefits of MCS in CTO PCI.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management

